Cryo-Cell International, Inc.
CCEL
$4.70
-$0.1267-2.63%
AMEX
| 05/31/2025 | 02/28/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -0.50% | -0.69% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.50% | -0.69% | |||
| Cost of Revenue | -6.45% | 21.26% | |||
| Gross Profit | 1.47% | -6.32% | |||
| SG&A Expenses | -8.20% | -22.83% | |||
| Depreciation & Amortization | -0.94% | -2.09% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.90% | -15.16% | |||
| Operating Income | 41.34% | 955.75% | |||
| Income Before Tax | 7.76% | 163.35% | |||
| Income Tax Expenses | -12.59% | -75.38% | |||
| Earnings from Continuing Operations | 25.77% | 115.20% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 25.77% | 115.20% | |||
| EBIT | 41.34% | 955.75% | |||
| EBITDA | 33.65% | 938.22% | |||
| EPS Basic | 25.71% | 115.16% | |||
| Normalized Basic EPS | 68.88% | 165.32% | |||
| EPS Diluted | 33.33% | 113.00% | |||
| Normalized Diluted EPS | 70.30% | 164.42% | |||
| Average Basic Shares Outstanding | -0.02% | 0.19% | |||
| Average Diluted Shares Outstanding | -0.91% | 1.65% | |||
| Dividend Per Share | -40.00% | 0.00% | |||
| Payout Ratio | -0.52% | 7.58% | |||